314 related articles for article (PubMed ID: 16274265)
1. Advanced magnetic resonance imaging techniques to evaluate CNS glioma.
Olsen KI; Schroeder P; Corby R; Vucic I; Bardo DM
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S3-11. PubMed ID: 16274265
[TBL] [Abstract][Full Text] [Related]
2. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
[TBL] [Abstract][Full Text] [Related]
3. Imaging of brain tumors: functional magnetic resonance imaging and diffusion tensor imaging.
Gupta A; Shah A; Young RJ; Holodny AI
Neuroimaging Clin N Am; 2010 Aug; 20(3):379-400. PubMed ID: 20708553
[TBL] [Abstract][Full Text] [Related]
4. Preoperative imaging of superficially located glioma resection using short inversion-time inversion recovery images in high-field magnetic resonance imaging.
Beppu T; Inoue T; Nishimoto H; Ogasawara K; Ogawa A; Sasaki M
Clin Neurol Neurosurg; 2007 May; 109(4):327-34. PubMed ID: 17275995
[TBL] [Abstract][Full Text] [Related]
5. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of cerebral glioma with advanced magnetic resonance techniques].
Graça J; Palma T; Pereira P; Medina P; Ribeiro C; Evangelista P
Acta Med Port; 2003; 16(3):117-23. PubMed ID: 12868389
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced susceptibility-weighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner.
Ulmer S; Reeh M; Krause J; Herdegen T; Heldt-Feindt J; Jansen O; Rohr A
J Neurosci Methods; 2008 Jul; 172(2):168-72. PubMed ID: 18538856
[TBL] [Abstract][Full Text] [Related]
8. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
9. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
10. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
11. The role of advanced MR imaging in understanding brain tumour pathology.
Price SJ
Br J Neurosurg; 2007 Dec; 21(6):562-75. PubMed ID: 18071983
[TBL] [Abstract][Full Text] [Related]
12. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
13. Progress in magnetic resonance imaging of brain tumours.
Lemort M; Canizares-Perez AC; Van der Stappen A; Kampouridis S
Curr Opin Oncol; 2007 Nov; 19(6):616-22. PubMed ID: 17906462
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
15. 3.0-T functional brain imaging: a 5-year experience.
Scarabino T; Giannatempo GM; Popolizio T; Tosetti M; d'Alesio V; Esposito F; Di Salle F; Di Costanzo A; Bertolino A; Maggialetti A; Salvolini U
Radiol Med; 2007 Feb; 112(1):97-112. PubMed ID: 17310287
[TBL] [Abstract][Full Text] [Related]
16. Advanced MRI of adult brain tumors.
Young GS
Neurol Clin; 2007 Nov; 25(4):947-73, viii. PubMed ID: 17964022
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal magnetic resonance imaging of brain tumors].
Guillevin R; Menuel C; Vallée JN
Rev Neurol (Paris); 2011 Oct; 167(10):704-14. PubMed ID: 21903235
[TBL] [Abstract][Full Text] [Related]
19. Brain MRI: tumor evaluation.
Young RJ; Knopp EA
J Magn Reson Imaging; 2006 Oct; 24(4):709-24. PubMed ID: 16958058
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma.
Chang J; Thakur SB; Huang W; Narayana A
Technol Cancer Res Treat; 2008 Oct; 7(5):349-62. PubMed ID: 18783284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
